Mangalpady S, Pena-Corona S, Borbolla-Jimenez F, Kaverikana R, Shetty S, Shet V
Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(9):6317-6336.
PMID: 38652277
DOI: 10.1007/s00210-024-03095-7.
Mesas C, Chico M, Doello K, Lara P, Moreno J, Melguizo C
Int J Mol Sci. 2024; 25(2).
PMID: 38255911
PMC: 10815318.
DOI: 10.3390/ijms25020837.
Gag O, Dinu S, Manea H, Marcovici I, Pinzaru I, Popovici R
Life (Basel). 2023; 13(5).
PMID: 37240789
PMC: 10221048.
DOI: 10.3390/life13051144.
Salvador D, Bastos V, Oliveira H
Int J Mol Sci. 2022; 23(7).
PMID: 35408947
PMC: 8998307.
DOI: 10.3390/ijms23073586.
Kis B, Pavel I, Avram S, Moaca E, Herrero San Juan M, Schwiebs A
BMC Complement Med Ther. 2022; 22(1):74.
PMID: 35296309
PMC: 8928639.
DOI: 10.1186/s12906-022-03526-z.
In Vitro Assessment of the Cytotoxic and Antiproliferative Profile of Natural Preparations Containing Bergamot, Orange and Clove Essential Oils.
Alexa V, Galuscan A, Soica C, Cozma A, Coricovac D, Borcan F
Molecules. 2022; 27(3).
PMID: 35164253
PMC: 8838259.
DOI: 10.3390/molecules27030990.
Long non-coding RNA (lncRNA) CYTOR promotes hepatocellular carcinoma proliferation by targeting the microRNA-125a-5p/LASP1 axis.
Liu Y, Geng X
Bioengineered. 2022; 13(2):3666-3679.
PMID: 35081873
PMC: 8974008.
DOI: 10.1080/21655979.2021.2024328.
Long non‑coding RNA LINC00238 suppresses the malignant phenotype of liver cancer by sponging miR‑522.
Qian H, Wu Q, Wu J, Tian X, Xu W, Hao C
Mol Med Rep. 2022; 25(2).
PMID: 35014686
PMC: 8767542.
DOI: 10.3892/mmr.2022.12587.
Vitamin D Enhances Anticancer Properties of Cediranib, a VEGFR Inhibitor, by Modulation of VEGFR2 Expression in Melanoma Cells.
Piotrowska A, Beserra F, Wierzbicka J, Nowak J, Zmijewski M
Front Oncol. 2022; 11:763895.
PMID: 35004285
PMC: 8740239.
DOI: 10.3389/fonc.2021.763895.
The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval.
Matias M, Pinho J, Penetra M, Campos G, Reis C, Gaspar M
Cells. 2021; 10(11).
PMID: 34831311
PMC: 8621991.
DOI: 10.3390/cells10113088.
Design, synthesis, and biological evaluation of symmetrical azine derivatives as novel tyrosinase inhibitors.
Karimian S, Kazemi F, Attarroshan M, Gholampour M, Hemmati S, Sakhteman A
BMC Chem. 2021; 15(1):54.
PMID: 34587988
PMC: 8480273.
DOI: 10.1186/s13065-021-00780-z.
Real-time cancer diagnosis of breast cancer using fluorescence lifetime endoscopy based on the pH.
Lee J, Kim B, Park B, Won Y, Kim S, Lee S
Sci Rep. 2021; 11(1):16864.
PMID: 34413447
PMC: 8376886.
DOI: 10.1038/s41598-021-96531-0.
Design, Synthesis, and Biological Evaluation of Stable Colchicine-Binding Site Tubulin Inhibitors 6-Aryl-2-benzoyl-pyridines as Potential Anticancer Agents.
Chen H, Deng S, Albadari N, Yun M, Zhang S, Li Y
J Med Chem. 2021; 64(16):12049-12074.
PMID: 34378386
PMC: 9206500.
DOI: 10.1021/acs.jmedchem.1c00715.
Paclitaxel anticancer activity is enhanced by the MEK 1/2 inhibitor PD98059 in vitro and by PD98059-loaded nanoparticles in BRAF melanoma-bearing mice.
Mekkawy A, Naguib Y, Alhaj-Suliman S, Wafa E, Ebeid K, Acri T
Int J Pharm. 2021; 606:120876.
PMID: 34252520
PMC: 8429118.
DOI: 10.1016/j.ijpharm.2021.120876.
Fortuitous discovery of melanomas in the ENT Department - a histopathological and immunohistochemical study.
Trandafir C, Tischer A, Horhat I, Balica N, Sitaru A, Guran K
Rom J Morphol Embryol. 2021; 61(4):1163-1171.
PMID: 34171065
PMC: 8343656.
DOI: 10.47162/RJME.61.4.18.
Immunohistochemical study of CD117 in various cutaneous melanocytic lesions.
Radu A, Bejenaru C, tolea I, Maranduca M, Branisteanu D, Bejenaru L
Exp Ther Med. 2020; 21(1):78.
PMID: 33363589
PMC: 7725021.
DOI: 10.3892/etm.2020.9510.
Correlations on Phenolic Screening Related to In Vitro and In Ovo Assessment of L. Hydro-Alcoholic Extracts Used as Skin Active Ingredient.
Faur A, Watz C, Moaca E, Avram S, Borcan F, Pinzaru I
Molecules. 2020; 25(22).
PMID: 33233640
PMC: 7699777.
DOI: 10.3390/molecules25225442.
Pan-cancer analysis reveals TAp63-regulated oncogenic lncRNAs that promote cancer progression through AKT activation.
Napoli M, Li X, Ackerman H, Deshpande A, Barannikov I, Pisegna M
Nat Commun. 2020; 11(1):5156.
PMID: 33056990
PMC: 7561725.
DOI: 10.1038/s41467-020-18973-w.
Inhibition of Patched Drug Efflux Increases Vemurafenib Effectiveness against Resistant Braf Melanoma.
Signetti L, Elizarov N, Simsir M, Paquet A, Douguet D, Labbal F
Cancers (Basel). 2020; 12(6).
PMID: 32526884
PMC: 7352342.
DOI: 10.3390/cancers12061500.
Phytochemical and Biological Screening of L. Hydroalcoholic Extract.
Fecker R, Buda V, Alexa E, Avram S, Pavel I, Muntean D
Biomolecules. 2020; 10(6).
PMID: 32466573
PMC: 7356052.
DOI: 10.3390/biom10060818.